Hengruiyuan

About:

Hengruiyuan is a biopharmaceutical company that develops medications based on immune cell treatment technologies for solid tumors.

Website: http://www.shhryz.com

Top Investors: Goldport Capital, Zhongke Kechuang, Jiangsu Hengrui Medicine

Description:

Hengruiyuan is a biopharmaceutical company that develops medications based on immune cell treatment technologies for solid tumors.

Total Funding Amount:

300M CNY

Headquarters Location:

Songjiang, Shanghai, China

Founded Date:

2015-01-01

Contact Email:

hryz(AT)shhryz.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2024-01-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai